{"id":826471,"date":"2025-03-17T14:36:54","date_gmt":"2025-03-17T18:36:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/"},"modified":"2025-03-17T14:36:54","modified_gmt":"2025-03-17T18:36:54","slug":"novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/","title":{"rendered":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  17, 2025  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Novo Nordisk A\/S (NYSE: NVO).<\/strong><\/p>\n<p>Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dqpgvVAyTt2fMVih47NYRzuP34lk-pLlc_Q6MAKbrGI-_yR7GBhAFuo3TcYsZneVuEanZnc0c8hCbvryJroXMDJi9S5ZBmEHTGnt4Kz2tqU2JupYJTKVDE7dPsE9tNUHyDC5Pd_21WTYwk4bw2YutjYRHtyP6nOBlxN2DDYIvrsWrMgXO6J2Z9GaXWEWiNvgKyO37CetR0Qy4ySP15RMAj-ILSMYw_3aUZRyHbezRCzsJYSLMbsgOJtFyXDTOm18dvkIFON0lrvC3FEXLkp1sHd1_EcxwZkKfUBM1ghjVAjeHV17ECOKKEz1DuYabqHu\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/novo-nordisk-a-s-loss-submission-form\/?id=136052&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>November 2, 2022 to December 19, 2024<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their \u201cREDEFINE 1\u201d trial, \u201ca 68-week efficacy and safety trial investigating subcutaneous CagriSema.\u201d The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well short of Novo\u2019s targeted expectation of at least 25% weight loss. The press release further indicated that participant patients were permitted to modify their own dosage during the trial and, as a result, only 57.3% of patients treated with CagriSema were on the highest dosage contemplated by the study. Following this news, Novo\u2019s stock price fell by $18.44 per share to close at $85.00 per share.<\/p>\n<p>\n        <strong>DEADLINE: March 25, 2025<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dqpgvVAyTt2fMVih47NYRzuP34lk-pLlc_Q6MAKbrGI-_yR7GBhAFuo3TcYsZneVuEanZnc0c8hCbvryJroXMDJi9S5ZBmEHTGnt4Kz2tqU2JupYJTKVDE7dPsE9tNUHyDC5Pd_21WTYwk4bw2YutsMuWY_Rc1Cg-r0zVJcBHOmVPDALrHRzAIDTE9Cwok6Xk9-PqI3CiKtr2No22W0bUBprQtkU8Af3MArnE-F7cCR5GItkQcxru3vcIt0HZ2Li_8uP7hVtPUKyhgdjITGqE55dLrkX6rbCdzAJnLipjQZpe2b-rCGXqHecJ02TMFOQ\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/novo-nordisk-a-s-loss-submission-form\/?id=136052&amp;from=3<\/a>\u00a0<\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of NVO during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 25, 2025. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_MgTWNBo5UUR04dPuTeheXjF-8SKkwKgyScuAKEpHywMwwaMQmmsgWb8c__lJNfJ-bnIRFjjuWiF-33kfhXScu7loTKvNCuZfx91r563V4GXYyh1YPHo0mq9t3zeYbp6\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a>\u00a0<br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTBhYzNhYjctODJmZC00N2FmLWE3OGYtMmIzN2YyYzE3MzkzLTEyNzA0NjctMjAyNS0wMy0xNy1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A\/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/novo-nordisk-a-s-loss-submission-form\/?id=136052&amp;from=3\u00a0 CLASS PERIOD: November 2, 2022 to December 19, 2024 ALLEGATIONS: According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their \u201cREDEFINE 1\u201d trial, \u201ca 68-week efficacy and safety trial investigating subcutaneous CagriSema.\u201d The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-826471","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A\/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/novo-nordisk-a-s-loss-submission-form\/?id=136052&amp;from=3\u00a0 CLASS PERIOD: November 2, 2022 to December 19, 2024 ALLEGATIONS: According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their \u201cREDEFINE 1\u201d trial, \u201ca 68-week efficacy and safety trial investigating subcutaneous CagriSema.\u201d The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well &hellip; Continue reading &quot;Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T18:36:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novo Nordisk A\\\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO\",\"datePublished\":\"2025-03-17T18:36:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/\"},\"wordCount\":414,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/\",\"name\":\"Novo Nordisk A\\\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\",\"datePublished\":\"2025-03-17T18:36:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk A\\\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk","og_description":"NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A\/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/novo-nordisk-a-s-loss-submission-form\/?id=136052&amp;from=3\u00a0 CLASS PERIOD: November 2, 2022 to December 19, 2024 ALLEGATIONS: According to the complaint, on December 20, 2024, Novo issued a press release announcing the below-expected results of their \u201cREDEFINE 1\u201d trial, \u201ca 68-week efficacy and safety trial investigating subcutaneous CagriSema.\u201d The trial showed that patients treated with CagriSema exhibited weight loss of 22.7% after 68 weeks, well &hellip; Continue reading \"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-17T18:36:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO","datePublished":"2025-03-17T18:36:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/"},"wordCount":414,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/","name":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=","datePublished":"2025-03-17T18:36:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5NDkwOSM2ODA3MzQ4IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novo-nordisk-a-s-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-march-25-2025-to-discuss-your-rights-nvo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk A\/S Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights \u2013 NVO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=826471"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/826471\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=826471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=826471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=826471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}